BPC-157 Cannabis Interaction Profile: What the Evidence Actually Shows
At a glance
- Direct interaction data / No study of BPC-157 with cannabis, THC or CBD is described in FDA's review [1]
- BPC-157 status / Not FDA-approved; no approved product contains it [1]
- Human pharmacokinetics / No data for oral, subcutaneous, nasal or skin use [1]
- Mechanism / Molecular targets not identified; poorly understood [1]
- Cannabis effects / Acute THC raises dopamine release; cannabis overdose can raise heart rate and change blood pressure [2][3]
- Gut overlap / Endocannabinoid system regulates GI motility; BPC-157 healed gut lesions in rats [4][5]
- Main uncertainty / Combined human effects are unmeasured
What is known about taking BPC-157 with cannabis?
BPC-157 is a synthetic 15-amino-acid peptide sold as capsules, injections, oral sprays and nasal sprays, some labeled for research use only [1]. It is not an FDA-approved drug, and FDA's 2026 review found no approved product containing it in any country it searched [1]. So there is no FDA-approved label with an interaction section for BPC-157 [1].
The direct answer is short: FDA's review of the human studies of BPC-157 describes no study that gave it with cannabis, THC or CBD [1]. There is also no human pharmacokinetic data for BPC-157 by the oral, subcutaneous, nasal or skin routes [1]. After rectal enemas in two early studies, BPC-157 was mostly not detectable in blood, and FDA judged it appears not to be absorbed systemically by that route [1].
What people on Reddit report
Reddit users discussing cannabis alongside a peptide. Some say no interaction is known, one raises a growth hormone concern, and one describes personal daily use.
No contradictions published or that I've heard about anecdotally. They don't interact in anyway so it wouldn't make sense for it to be a problemRead the source discussion
THC acutely suppresses GH release, so you will have less GH available for the upregulated receptors from BPC.Read the source discussion
Been on bpc 157 & tb 500 for 2 weeks. Smoked everyday - recovery going extremely well.. as been told by the doctor yesterdayRead the source discussion
Questions worth asking
Do BPC-157 and cannabis share measurable pathways?
Only in separate observations, not in a tested combination. FDA says BPC-157's molecular targets have not been identified and its mechanisms remain poorly understood [1]. Animal work reports effects on nitric oxide, dopamine and serotonin systems [6][7]. One rat study found BPC-157 changed the effects of a nitric-oxide inhibitor on stomach lesions and blood pressure, and had no effect on normal resting blood pressure [7]. That study did not test cannabis. Rat work also reports gut lesion healing [5].
Cannabis has its own measured effects. Acute THC increases dopamine release and neuron activity, while long-term use is associated with blunting of the dopamine system [2]. Cannabis overdose can increase heart rate and change blood pressure [3]. The endocannabinoid system is an important regulator of gastrointestinal motility [4].
Those facts do not add up to an interaction profile. No study cited here measured BPC-157 and THC or CBD together, and the human effects of BPC-157 that would matter, such as changes in blood pressure, gut transit or dopamine tone, are not established.
What human evidence exists for BPC-157?
The human evidence is small and weak. A 2026 systematic review found 3 studies with 30 patients total, all of poor methodological quality, with certainty of evidence rated very low [8]. FDA found five small clinical studies, including a 2-person intravenous pilot, and concluded there is insufficient clinical safety information to characterize BPC-157's safety profile [1].
FDA's adverse-event database search through December 4, 2025 found 3 reports, all injectable BPC-157: injection-site redness and swelling for 9 days, shortness of breath leading to an emergency room visit, and widespread skin and gum darkening that recurred on re-exposure to a BPC-157 plus TB-500 product [1]. FDA said it cannot tell whether BPC-157 caused these events [1].
Animal toxicity signals include shortened clotting time in rats and prolonged clotting time in dogs in 28-day intramuscular studies, plus raised liver enzyme, glucose and triglyceride levels [1]. It is unknown whether cannabis changes any of those signals.
What is BPC-157's regulatory status?
BPC-157 is not FDA-approved and has no US Pharmacopeia or National Formulary monograph [1]. FDA placed it in category 2 for significant safety risks from September 2023 until April 22, 2026, then moved it to a nominated-but-withdrawn table after the nominators withdrew; it is not in category 1 [9][10]. A 2026 HHS draft enforcement-discretion policy for certain peptides is not an approval and does not put BPC-157 on FDA's pharmacy bulks list [11]. It is a non-binding statement that HHS does not intend to take enforcement action against certain state-licensed pharmacies and physicians if conditions are met [11].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Has BPC-157 been studied with cannabis?
Does THC interact with BPC-157?
Does CBD interact with BPC-157?
Is there an FDA label for BPC-157 interactions?
How long does BPC-157 stay in the body?
Does BPC-157 act on CB1 or CB2 receptors?
References
Show all 12 referencesHide references
- U.S. Food and Drug Administration.
- Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of Δ9-tetrahydrocannabinol on the dopamine system. Nature. 2016;539(7629):369-377.
- Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-60.
- Sharkey KA, Wiley JW. The Role of the Endocannabinoid System in the Brain-Gut Axis. Gastroenterology. 2016;151(2):252-66.
- Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-32.
- Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.
- Sikirić P, Seiwerth S, Grabarević Z, Rucman R, Petek M, Jagić V, et al. The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol. 1997;332(1):23-33.
- Poolton JT, Minett J, Kazmi A. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthop Belg. 2026;92(3).
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- Official web page.
- Reddit participants. Cannabis and Bpc 157 (r/bpc_157). Accessed 2026-11-10.